Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma

Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma

Patients with hepatocellular carcinoma (HCC) have a highly variable clinical course. Therefore, there is an urgent need to identify new prognostic markers to determine prognosis and select specific therapies. Recently, it has been demonstrated that dysregulation of the urea cycle (UC) is a common ph...

Full description

Bibliographic Details
Main Authors: Dirk Andreas Ridder, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Lana Urbansky, Hagen Roland Witzel, Stefan Heinrich, Wilfried Roth, Beate Katharina Straub
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
hepatocellular carcinoma
HCC
prognosis
biomarker
pyrimidine
cps1
Online Access:https://www.mdpi.com/2072-6694/13/4/744

Similar Items

Similar Items